Skip to main content
. 2017 May 5;8(37):60962–60974. doi: 10.18632/oncotarget.17631

Figure 4. CAT-1 increases HCC cell invasive ability.

Figure 4

(A, B) Metastasis and invasive ability of HepG2 cells treated with pCAT-1, psiCAT-1, pcDNA, psi-NC, pCAT-1 with psiCAT-1 as-determined by Transwell assays. Statistically significant differences are indicated: **p<0.01, ***p<0.001. Data represent mean ± SD. Experiments were performed in triplicate.